Journal of Biopharmaceutical Statistics

Taylor & Francis

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Biopharmaceutical Statistics is a journal published by Taylor & Francis in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Taylor & Francis
ISSN
1054-3406 · 1520-5711
Country
United Kingdom
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1991-01-01
  • PUBMED · 2013-03-11
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2607

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

72

i10-index

852

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
33%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
JBS
Source type
journal
NLM unique ID (PubMed)
9200436
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Statistical Methods and Bayesian Inference
  • Optimal Experimental Design Methods
  • Optimal Experimental Design Methods
  • Probability and Statistical Research
  • Pharmaceutical studies and practices
Show all subjects (75)
  • Statistical Methods and Bayesian Inference
  • Statistical Methods and Bayesian Inference
  • Statistical Methods and Inference
  • Statistical Methods and Inference
  • Optimal Experimental Design Methods
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Advanced Causal Inference Techniques
  • Advanced Causal Inference Techniques
  • Statistical Methods in Epidemiology
  • Advanced Causal Inference Techniques
  • Statistical Methods and Inference
  • Meta-analysis and systematic reviews
  • Meta-analysis and systematic reviews
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Biosimilars and Bioanalytical Methods
  • Statistical Distribution Estimation and Applications
  • Advanced Statistical Methods and Models
  • Advanced Statistical Methods and Models
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Advanced Statistical Process Monitoring
  • Advanced Statistical Process Monitoring
  • Gene expression and cancer classification
  • Gene expression and cancer classification
  • Meta-analysis and systematic reviews
  • Bayesian Methods and Mixture Models
  • Bayesian Methods and Mixture Models
  • Statistical Distribution Estimation and Applications
  • Statistical Distribution Estimation and Applications
  • Analytical Methods in Pharmaceuticals
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Statistical Methods and Applications
  • Gene expression and cancer classification
  • Pesticide Residue Analysis and Safety
  • Pesticide Residue Analysis and Safety
  • Pharmacovigilance and Adverse Drug Reactions
  • Reliability and Agreement in Measurement
  • Cardiac electrophysiology and arrhythmias
  • Advanced Statistical Methods and Models
  • Pharmaceutical Economics and Policy
  • Health Systems, Economic Evaluations, Quality of Life
  • Reliability and Agreement in Measurement
  • Reliability and Agreement in Measurement
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Pharmaceutical Economics and Policy
  • Advanced Multi-Objective Optimization Algorithms
  • Advanced Multi-Objective Optimization Algorithms
  • Pharmaceutical Economics and Policy
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Advanced Statistical Process Monitoring
  • Pharmacogenetics and Drug Metabolism
  • Simulation Techniques and Applications
  • Pharmacogenetics and Drug Metabolism
  • Spectroscopy and Chemometric Analyses
  • Spectroscopy and Chemometric Analyses
  • Bayesian Methods and Mixture Models
  • Breast Cancer Treatment Studies
  • SAS software applications and methods

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: